|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02697 TH MEDICAL-B
Nominal 
288.000 +3.600 (+1.266%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Turnover | 5,671 | 3178.035% | 12,178 | 1,791 |
| Cost of Sales | (1,308) | 2194.737% | (2,884) | (481) |
| Gross Profit | 4,363 | 3661.207% | 9,294 | 1,310 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (68) | -- | (123) | (34) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (66) | -- | (161) | 0 | |
| Profit / (Loss) before Taxation | (60,424) | 6.504% | (90,112) | (92,153) | |
| Taxation | 0 | -- | (1) | (3) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (60,424) | 6.504% | (90,113) | (92,156) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 14 | 133.333% | (91) | (29) |
| Depreciation & Amortisation | 5,998 | -17.017% | 13,604 | 12,652 |
| Directors' Emoluments | -- | -- | 6,944 | 6,235 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | |
| EPS (cts) | -188.000 | -4.082% | -- | -- |
| DPS (cts) | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- |
| NBV per share ($) | 15.228 | -- | -- | -- |
| Remarks: | Real time quote last updated: 21/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -60,424 |
| %Change | 6.504% |
| EPS / (LPS) | RMB -1.880 |
| NBV Per Share (¥) | RMB 15.228 |